Your browser doesn't support javascript.
loading
A ubiquitin-independent proteasome pathway controls activation of the CARD8 inflammasome.
Hsiao, Jeffrey C; Neugroschl, Atara R; Chui, Ashley J; Taabazuing, Cornelius Y; Griswold, Andrew R; Wang, Qinghui; Huang, Hsin-Che; Orth-He, Elizabeth L; Ball, Daniel P; Hiotis, Giorgos; Bachovchin, Daniel A.
Affiliation
  • Hsiao JC; Pharmacology Program of the Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Neugroschl AR; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Chui AJ; Tri-Institutional PhD Program, Weill Cornell Medical College, Rockefeller University and Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Taabazuing CY; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Griswold AR; Tri-Institutional MD-PhD Program, Weill Cornell Medical College, Rockefeller University and Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Wang Q; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Huang HC; Tri-Institutional PhD Program, Weill Cornell Medical College, Rockefeller University and Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Orth-He EL; Tri-Institutional PhD Program, Weill Cornell Medical College, Rockefeller University and Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Ball DP; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Hiotis G; Tri-Institutional PhD Program, Weill Cornell Medical College, Rockefeller University and Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Bachovchin DA; Pharmacology Program of the Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Tri-Institutional PhD Program, Weill Cornell Medical College, Roc
J Biol Chem ; 298(7): 102032, 2022 07.
Article in En | MEDLINE | ID: mdl-35580636
ABSTRACT
CARD8 is a pattern-recognition receptor that forms a caspase-1-activating inflammasome. CARD8 undergoes constitutive autoproteolysis, generating an N-terminal (NT) fragment with a disordered region and a ZU5 domain and a C-terminal (CT) fragment with UPA and CARD domains. Dipeptidyl peptidase 8 and dipeptidyl peptidase 9 inhibitors, including Val-boroPro, accelerate the degradation of the NT fragment via a poorly characterized proteasome-mediated pathway, thereby releasing the inflammatory CT fragment from autoinhibition. Here, we show that the core 20S proteasome, which degrades disordered and misfolded proteins independent of ubiquitin modification, controls activation of the CARD8 inflammasome. In unstressed cells, we discovered that the 20S proteasome degrades just the NT disordered region, leaving behind the folded ZU5, UPA, and CARD domains to act as an inhibitor of inflammasome assembly. However, in Val-boroPro-stressed cells, we show the 20S proteasome degrades the entire NT fragment, perhaps due to ZU5 domain unfolding, freeing the CT fragment from autoinhibition. Taken together, these results show that the susceptibility of the CARD8 NT domain to 20S proteasome-mediated degradation controls inflammasome activation.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proteasome Endopeptidase Complex / CARD Signaling Adaptor Proteins / Inflammasomes Limits: Humans Language: En Journal: J Biol Chem Year: 2022 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proteasome Endopeptidase Complex / CARD Signaling Adaptor Proteins / Inflammasomes Limits: Humans Language: En Journal: J Biol Chem Year: 2022 Document type: Article Affiliation country: Estados Unidos